See photos from our major fundraiser honoring Exon 20 Group Founder Kevin Hanlon, supporting our research and advocacy projects!
Donate Now!
A special initiative of ICAN, International Cancer Advocacy Network
The Exon 20 Group is a laser-focused, multi-stakeholder, global coalition of patients, care partners, family members, thoracic/medical oncologists, scientists, molecular profiling labs, and pharmaceutical companies and biotechs with the mission of converting exon 20 insertion mutations into chronic diseases and then curing them. Join us!
Membership in the Exon 20 Group is FREE, but we do "onboarding" of each patient first before you can join our community. Please complete our
New Patient Form
Alternatively, you may call to schedule an onboarding appointment so that you can access our numerous free services, 602-618-0183. Introductory emails describing your particular situation are welcome before we schedule our phone call with you. Send to exon20@exon20group.org
Since ICAN and the Exon 20 Group strictly adhere to all HIPAA (Health Insurance Portability and Accountability Act of 1996) provisions to protect your privacy, during our initial intake call/meeting with you, we will review, and you will have a chance to discuss with us our Navigation Consent forms.
We never sell your information and only release information with your explicit permission (for example, when setting up a second opinionat your request, applying for expanded access/compassionate use, or inquiring about a clinical trial).
To volunteer to work on one of the Exon 20 Group's many satellites, task forces, or committees, please email marcia@exon20group.org
Recruiting new members for:
*Marcia K. Horn is President and CEO of
ICAN International Cancer Advocacy Network and
Executive Director of
the Exon 20 Group.
The Exon 20 Group is a special initiative of
ICAN, International Cancer Advocacy Network—a 501(c)(3) charitable organization,
EIN 86-0818253.